Bandidwattanawong, 2023 - Google Patents
Squamous Cell Carcinoma of Head and NeckBandidwattanawong, 2023
View HTML- Document ID
- 10062906782703284276
- Author
- Bandidwattanawong C
- Publication year
- Publication venue
- Clinical Diagnosis and Management of Squamous Cell Carcinoma
External Links
Snippet
Squamous cell carcinoma of head and neck (SCCHN) is the most common cancer arising in the head and neck region. Smoking and heavy alcohol drinking are still the well-established causes of most cases worldwide; however, human papillomavirus (HPV) infection is the …
- 208000000102 Squamous Cell Carcinoma of Head and Neck 0 title abstract description 51
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Economopoulou et al. | Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting | |
Lassen | The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome | |
Langer | Exploring biomarkers in head and neck cancer | |
Ren et al. | HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers | |
Coca-Pelaz et al. | Adenoid cystic carcinoma of the head and neck–An update | |
Goon et al. | HPV & head and neck cancer: a descriptive update | |
Ang et al. | Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma | |
Machiels et al. | Advances in the management of squamous cell carcinoma of the head and neck | |
Ramqvist et al. | An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention | |
Chernock et al. | Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx | |
Urban et al. | What is the best treatment for patients with human papillomavirus–positive and–negative oropharyngeal cancer? | |
Marur et al. | Head and neck cancer: changing epidemiology, diagnosis, and treatment | |
McGovern et al. | Three synchronous HPV‐associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization | |
Sirinian et al. | RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling | |
Tsakonas et al. | c-MET as a biomarker in patients with surgically resected non-small cell lung cancer | |
Pogorzelski et al. | Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy | |
Orita et al. | Laryngeal squamous cell papilloma is highly associated with human papillomavirus | |
Kwon et al. | Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus–negative tonsillar squamous cell carcinoma and their prognostic significances | |
Wang et al. | Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma | |
Tawk et al. | Evolution of a paradigm switch in diagnosis and treatment of HPV-driven head and neck cancer—striking the balance between toxicity and cure | |
Yi et al. | HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53 | |
Raju et al. | Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma | |
Beuselinck et al. | RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs | |
Liau et al. | Frequent PIK 3 CA activating mutations in nipple adenomas | |
Woelber et al. | Targeted therapeutic approaches in vulvar squamous cell cancer (VSCC): case series and review of the literature |